tirzepatide shortages Lilly's weight-loss drug removed from FDA's shortage list Ozempic and weight loss drug

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes (Phase 2)

My current take on the subject is this: L-carnitine may modestly increase cardiovascular risk if taken over long periods of time

It is important to remember that individual results will vary based on lifestyle, starting weight, and adherence to the treatment plan

Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy

GSH turnover will be assessed on whole animals by injection of radiolabeled precursors

The medium-term outlook, assuming safety data remains reassuring, is very optimistic, with drug-effectiveness approaching that of obesity surgery, which remains the gold standard treatment in terms of effectiveness and value for money